Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

NCT07287644

RecruitingPhase 2, Phase 3

Sponsor: Bluefin Biomedicine, Inc.

Conditions: Hidradenitis Suppurativa (HS)

Interventions: BFB759, Placebo for BFB759

Countries: United States, Bulgaria, Canada, Czechia, Germany, Poland, Spain

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.

Eligibility overview

Sex: ALL

Age: 18 Years to 75 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Are adults (18 to 75 years) with a diagnosis of hidradenitis suppurativa for at least one year.
* Have moderate to severe disease not well controlled by systemic antibiotic treatment.
* Are willing to follow study instructions, attend regular visits, and avoid certain other medications during the study.

Exclusion Criteria:

* Have certain infections or other immune conditions.
* Recently used medications that could interfere with the study.
* Are pregnant or breastfeeding.
Locations (58)
  • Phoenix, Arizona, United States
  • Encino, California, United States
  • Santa Monica, California, United States
  • Boca Raton, Florida, United States
  • Fort Lauderdale, Florida, United States
  • North Miami Beach, Florida, United States
  • Tampa, Florida, United States
  • Atlanta, Georgia, United States
  • Douglasville, Georgia, United States
  • Plainfield, Indiana, United States
  • Louisville, Kentucky, United States
  • Mandeville, Louisiana, United States
  • Metairie, Louisiana, United States
  • New Orleans, Louisiana, United States
  • Auburn Hills, Michigan, United States
  • Northville, Michigan, United States
  • Wildwood, Missouri, United States
  • Las Vegas, Nevada, United States
  • Reno, Nevada, United States
  • Hackensack, New Jersey, United States
  • The Bronx, New York, United States
  • Boardman, Ohio, United States
  • Canton, Ohio, United States
  • Mayfield Heights, Ohio, United States
  • Pittsburgh, Pennsylvania, United States
  • Charleston, South Carolina, United States
  • Mt. Pleasant, South Carolina, United States
  • Smyrna, Tennessee, United States
  • Prosper, Texas, United States
  • Southlake, Texas, United States
  • + 28 more on CT.gov